Podack; Eckhard R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Podack; Eckhard R..The latest application filed is for "immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists, and immunotoxins".

Company Profile

5.18.29

Podack; Eckhard R. - Coconut Grove FL
Podack; Eckhard R. - Miami FL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins Grant 11,395,846 - Podack , et al. July 26, 2	2022-07-26
Compositions comprising TLIA-Ig fusion protein for the regulation of T regulatory cells, and methods for their use Grant RE48,599 - Podack , et al. June 22, 2	2021-06-22
Method for in vivo expansion of T regulatory cells Grant 10,934,364 - Podack , et al. March 2, 2	2021-03-02
Immunomodulating Tumor Necrosis Factor Receptor 25 (tnfr25) Agonists, Antagonists, And Immunotoxins App 20200345809 - PODACK; Eckhard R. ; et al.	2020-11-05
Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins Grant 10,624,950 - Podack , et al.	2020-04-21
Tumor Vaccine App 20190175706 - Podack; Eckhard R.	2019-06-13
Tumor vaccine Grant 10,279,020 - Podack	2019-05-07
Method for In Vivo Expansion of T Regulatory Cells App 20180230226 - Podack; Eckhard R. ; et al.	2018-08-16
Immunomodulating Tumor Necrosis Factor Receptor 25 (tnfr25) Agonists, Antagonists, And Immunotoxins App 20180078611 - Podack; Eckhard R. ; et al.	2018-03-22
Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins Grant 9,839,670 - Podack , et al. December 12, 2	2017-12-12
Method for In Vivo Expansion of T Regulatory Cells App 20170226218 - Podack; Eckhard R. ; et al.	2017-08-10
Compositions comprising TL1A-Ig fusion protein for the regulation of T regulatory cells, and methods for their use Grant 9,603,925 - Podack , et al. March 28, 2	2017-03-28
Method for in vivo expansion of T regulatory cells Grant 9,499,627 - Podack , et al. November 22, 2	2016-11-22
Perforin-2 Activators And Inhibitors As Drug Targets For Infectious Disease And Gut Inflammation App 20160250303 - Podack; Eckhard R. ; et al.	2016-09-01
Tumor Vaccine App 20160045583 - Podack; Eckhard R.	2016-02-18
Immunomodulating Tumor Necrosis Factor Receptor 25 (tnfr25) Agonists, Antagonists, And Immunotoxins App 20160015779 - Podack; Eckhard R. ; et al.	2016-01-21
Allogeneic cancer cell-based immunotherapy Grant 9,238,064 - Podack , et al. January 19, 2	2016-01-19
Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins Grant 9,017,679 - Podack , et al. April 28, 2	2015-04-28
Heat shock protein GP96 vaccination and methods of using same Grant 8,968,720 - Podack , et al. March 3, 2	2015-03-03
Modified Heat Shock Protein-antigenic Peptide Complex App 20140335086 - Podack; Eckhard R. ; et al.	2014-11-13
Combined Cell Based Gp96-ig-siv/hiv, Recombinant Gp120 Protein Vaccination For Protection From Siv/hiv App 20140286991 - Podack; Eckhard R. ; et al.	2014-09-25
Compositions and Methods for the Regulation of T Regulatory Cells Using TL1A-Ig Fusion Protein App 20140286897 - Podack; Eckhard R. ; et al.	2014-09-25
Compositions and Methods for the Regulation of T Regulatory Cells Using TL1A-Ig Fusion Protein App 20140193410 - Podack; Eckhard R. ; et al.	2014-07-10
Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex Grant 8,685,384 - Podack , et al. April 1, 2	2014-04-01
Hiv/siv Vaccines For The Generation Of Mucosal And Systemic Immunity App 20140037682 - PODACK; ECKHARD R. ; et al.	2014-02-06
Allogeneic Cancer Cell-based Immunotherapy App 20130302376 - Podack; Eckhard R. ; et al.	2013-11-14
Allogeneic cancer cell-based immunotherapy Grant 8,475,785 - Podack , et al. July 2, 2	2013-07-02
Compositions and Methods for Treating Inflammatory Lung Disease App 20120328559 - Podack; Eckhard R. ; et al.	2012-12-27
Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins App 20120321645 - Podack; Eckhard R. ; et al.	2012-12-20
Method for in vivo expansion of T regulatory cells App 20120135011 - Podack; Eckhard R. ; et al.	2012-05-31
Tnfr25 Agonists To Enhance Immune Responses To Vaccines App 20120029472 - Podack; Eckhard R. ; et al.	2012-02-02
Cancer Treatment App 20110287057 - PODACK; ECKHARD R.	2011-11-24
Allogeneic Cancer Cell-based Immunotherapy App 20110250229 - Podack; Eckhard R. ; et al.	2011-10-13
Immunomodulating Tumor Necrosis Factor Receptor 25 (tnfr25) Agonists, Antagonists And Immunotoxins App 20110243951 - Podack; Eckhard R. ; et al.	2011-10-06
Hiv/siv Vaccines For The Generation Of Mucosal And Systemic Immunity App 20110223196 - Podack; Eckhard R. ; et al.	2011-09-15
Regulation Of Lymphocytes And Uses Therefor App 20110195048 - Podack; Eckhard R.	2011-08-11
Heat Shock Protein Gp96 Vaccination And Methods Of Using Same App 20110171211 - Podack; Eckhard R. ; et al.	2011-07-14
Tumor vaccine App 20090162404 - Podack; Eckhard R.	2009-06-25
Perforin-2 Proteins App 20090142768 - Podack; Eckhard R. ; et al.	2009-06-04
Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex App 20080026012 - Podack; Eckhard R. ; et al.	2008-01-31
Compositions and methods for treating inflammatory lung disease App 20080003221 - Podack; Eckhard R.	2008-01-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.